A Novel Protein Target, PTP1B, Shows Promise in Combating Alzheimer’s Disease by Enhancing Brain’s Immune Cell Function and Clearing Amyloid Plaques

Alzheimer’s disease is often described in numbers, with millions of people affected, cases rising quickly, and costs reaching into the trillions. For families, however, the experience is deeply personal. "It’s…

Single-nucleus chromatin accessibility profiling identifies cell types and functional variants contributing to major depression

Researchers at McGill University and the Douglas Institute have unveiled a groundbreaking discovery: two distinct types of brain cells exhibit significantly different functionalities in individuals diagnosed with depression. This pivotal…